Methanthelinium
ALIMENTARY TRACT AND METABOLISM
Also known as: banthine, methanthelin, methantheline, methantheline bromide, methanthelinium bromide
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Methanthelinium is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1951. DrugCentral lists 1 molecular target, including CHRM2|CHRM4|CHRM5|CHRM1|CHRM3. Recorded indications include Gastric ulcer, Peptic ulcer and Urinary incontinence.
- Approval status: ofm (first approved 1951 by the FDA).
- Molecular targets: CHRM2|CHRM4|CHRM5|CHRM1|CHRM3 (1 listed in DrugCentral).
- Indications: Gastric ulcer, Peptic ulcer and Urinary incontinence.
- ATC code: A03AB07 (Synthetic anticholinergics, quaternary ammonium compounds).
- Molecular formula: C21H26NO3; molecular weight 340.44 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (3)
- Gastric ulcer
- Peptic ulcer
- Urinary incontinence
Off-label uses (1)
- Irritable bowel syndrome
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Muscarinic acetylcholine receptor | CHRM2|CHRM4|CHRM5|CHRM1|CHRM3 | antagonist | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1951-07-03 | FDA | — | SHIRE |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
A03AB07 | ALIMENTARY TRACT AND METABOLISM › DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS › DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS › Synthetic anticholinergics, quaternary ammonium compounds |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Methanthelinium is on its molecule page.
| Molecular formula | C21H26NO3 |
|---|---|
| Molecular weight | 340.44 g/mol |
| CAS number | 5818-17-7 |
| InChIKey | GZHFODJQISUKAY-UHFFFAOYSA-N |
| PubChem CID | 4097 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Methanthelinium used for?
DrugCentral lists the following indications for Methanthelinium: Gastric ulcer, Peptic ulcer and Urinary incontinence.
How does Methanthelinium work?
Its molecular targets in DrugCentral include CHRM2|CHRM4|CHRM5|CHRM1|CHRM3 (antagonist).
When was Methanthelinium first approved?
Methanthelinium was first approved by the FDA in 1951.
What is the chemical formula of Methanthelinium?
Methanthelinium has the molecular formula C21H26NO3 and a molecular weight of 340.44 g/mol.
Browse: all drugs starting with M · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1736 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200988 — compound record and bioactivity
- PubChem CID 4097 — chemical identifiers
- DrugBank DB00940 — drug record
- FDA UNII 36EI79TX7I — substance identity
- DailyMed: FDA labels for Methanthelinium — current prescribing information (label search)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.